IBRNvsSDG
iShares Neuroscience and Healthcare ETF against iShares MSCI Global Impact ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBRN | SDG | |
|---|---|---|
| Expense ratio | 0.47% | 0.49% |
| Assets | $7931.50T | $175M |
| Net flow, 1 month | +$2M | −$893K |
| Net flow, 1 year | +$2M | −$17M |
| Return, YTD | +27.9% | +9.9% |
| Return, 1 year | +68.6% | +14.5% |
| Avg daily volume | 3K | 4K |
| Holdings | 54 | 189 |
| Listed | Aug 23, 2022 | Apr 19, 2016 |
| Options market | Yes | No |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS